[1]廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌.多囊卵巢综合征患者血清PTX3、vaspin 水平的观察研究[J].国际内分泌代谢杂志,2018,38(04):228-232.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
　Liao Xin*,Zhang Kaiyu,Gao Lin,et al.Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(04):228-232.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
点击复制

多囊卵巢综合征患者血清PTX3、vaspin 水平的观察研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年04期
页码:
228-232
栏目:
论著
出版日期:
2018-07-20

文章信息/Info

Title:
Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome
作者:
廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌
563099 贵州省遵义医学院附属医院内分泌科(廖鑫、高琳、张晗、张琳、李思成、张凌),核医学科(黄琦); 564100 贵州省遵义市湄潭县人民医院内科(张开羽); 563006 贵州省遵义医药高等专科学校护理系(邓凡曲)
Author(s):
Liao Xin*;  Zhang Kaiyu;  Gao Lin;  Zhang Han; Zhang Lin;  Deng Fanqu;  Huang Qi;  Li Sicheng;  Zhang Ling.*
Department of Endocrinology, Affiliated Hospital of Zunyi Medical University, Zunyi 563099, China
关键词:
多囊卵巢综合征;  肥胖;  PTX3;  Vaspin
Keywords:
Polycystic ovary syndrome;  Obesity;  PTX3;  Vaspin
DOI:
10.3760/cma.j.issn.1673-4157.2018.04.003
摘要:
目的 检测新诊断多囊卵巢综合征(PCOS)患者血清正五聚蛋白3(PTX3)和内脏脂肪特异性丝氨酸蛋白酶抑制剂(vaspin)水平,探讨其与PCOS不同表型的相关性。方法 入选遵义医学院附属医院内分泌科、生殖中心新诊断PCOS患者75例,另外选择健康对照者70名。根据体重指数分为非肥胖PCOS组(体重指数<23 kg/m2,n=33)、超重/肥胖 PCOS组(体重指数≥23 kg/m2,n=42)、非肥胖对照组(体重指数<23 kg/m2,n=34)、超重/肥胖对照组(体重指数≥23 kg/m2, n=36)。检测空腹血糖、甘油三酯、总胆固醇、高密度脂蛋白-胆固醇(HDL-C)、低密度脂蛋白-胆固醇(LDL-C)、空腹胰岛素(FINS)、雌二醇、硫酸脱氢表雄酮(DHEAS)、卵泡刺激素(FSH)、黄体生成素(LH)、孕酮、催乳素(PRL)、总睾酮等指标。ELISA测定血清PTX3、vaspin水平。采用稳态模型评估-胰岛素抵抗指数(HOMA-IR)评价胰岛素抵抗程度,并与PTX3、vaspin进行相关分析。结果 与非肥胖对照组相比,非肥胖PCOS组血清PTX3水平下降,vaspin水平升高(F=3.446、6.653,P均<0.05); 超重/肥胖PCOS组血清vaspin水平升高(F=4.125, P<0.05)。与非肥胖PCOS组相比,超重/肥胖对照组血清vaspin水平升高(F=6.238, P<0.05)。与超重/肥胖对照组相比,超重/肥胖PCOS组血清PTX3水平下降(F=5.273,P<0.01),vaspin水平升高(F=7.124,P<0.05)。血清PTX3与空腹血糖、甘油三酯、FINS、HOMA-IR、DHEAS、总睾酮呈负相关( r=-0.172、-0.190、-0.294、-0.274、-0.236、-0.243,P均<0.05), 与年龄呈正相关(r=0.240,P<0.05)。Vaspin与体重指数、HOMA-IR、总胆固醇呈正相关(r=0.331、0.418、0.172,P均<0.05)。结论 PCOS患者血清PTX3水平降低、vaspin水平升高,其水平变化可能与PCOS患者体内高雄激素血症及胰岛素抵抗有关。
Abstract:
Objective To determine the levels of serum pentraxin 3(PTX3)and visceral adipose tissue-derived serine protease inhibitor(vaspin)in newly-diagnosed polycystic ovary syndrome(PCOS)patients, and investigate the relationship between serum level of PTX3, vaspin and different phenotypes of PCOS.Methods Seventy five patients with newly-diagnosed PCOS and 70 age and body mass index(BMI)-matched healthy controls who visited the Department of Endocrinology and Reproduction Centre of the Affiliated Hospital of Zunyi Medical University were enrolled in the study. According to their BMI, the subjects were divided into non-obese PCOS group(BMI<23 kg/m2,n=33), overweight or obese PCOS group(BMI≥23kg/m2,n=42),non-obese control group(BMI<23 kg/m2,n=34)and overweight or obese control group(BMI≥23 kg/m2,n=36). Fasting plasma glucose(FPG),triglyceride(TG), total cholesterol(TC), high density lipoprotein-cholesterol(HDL-C), low density lipoprotein-cholesterol(LDL-C), fasting plasma insulin(FINS), etradiol(E2), dehydroepiandrosterone(DHEAS), follicle stimulating hormone(FSH), luteinizing hormone(LH), progesterone, prolactin(PRL)and total testosterone were measured. Serum PTX3 and vaspin levels were detected with ELISA. The homeostasis model assessment of insulin resistance(HOMA-IR)was used to estimate insulin resistance and its correlations with PTX3 and vaspin level were analyzed.Results Compared with non-obese control group, the level of PTX3 was reduced,while the level of vaspin was elevated in non-obese PCOS group(F=3.446,6.653,all P<0.05). The level of vaspin was elevated in overweight or obese PCOS group(F=4.125,P<0.05). Compared with non-obese PCOS group, the level of vaspin was elevated in overweight or obese PCOS group(F=6.238,P<0.05). Compared with overweight or obese control group, the level of serum PTX3 was reduced(F=5.273, P<0.01), and the level of vaspin was elevated(F=7.124, P<0.05)in overweight or obse PCOS group. Correlation analysis showed that the level of PTX3 was negatively correlated with FPG,TG,FINS,HOMA-IR, DHEAS and total testosterone(r=-0.172,-0.190,-0.294,-0.274,-0.236,-0.243, all P<0.05), and positively correlated with age(r=0.240,P<0.05). The level of vaspin was positively correlated with BMI, HOMA-IR and TC(r=0.331, 0.418, 0.172,all P<0.05).Conclusion PCOS patients have a low level of PTX3 but high level of vaspin, which might be related to hyperandrogenism and insulin resistance.

参考文献/References:


[1] Li R,Zhang Q,Yang D,et al.Prevalence of polycystic ovary syndrome in women in China: a large community-based study[J].Hum Reprod,2013,28(9):2562-2569.DOI:10.1093/humrep/det262.
[2] Inforzato A,Jaillon S,Moalli F,et al. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling[J].Tissue Antigens,2011,77(4):271-282.DOI: 10.1111/j.1399-0039.2011.01645.x.
[3] Mathus-Vliegen L,Toouli J,Fried M,et al. World Gastroenterology Organisation global guidelines on obesity[J].J Clin Gastroenterol,2012,46(7):555-561.DOI:10.1097/MCG.0b013e318259bd04.
[4] Karakas MF,Buyukkaya E,Kurt M,et al.Serum pentraxin-3 levels are associated with the severity of metabolic syndrome[J].Med Princ Pract,2013,22(3):274-279.DOI:10.1159/000343904.
[5] Ryu WS,Kim CK,Kim BJ,et al.Pentraxin 3: a novel and independent prognostic marker in ischemic stroke[J].Atherosclerosis,2012,220(2):581-586.DOI:10.1016/j.atherosclerosis.2011.11.036.
[6] Aydogdu A,Tasci I,Tapan S,et al. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome[J].Gynecol Endocrinol,2012,28(9):722-725.DOI:10.3109/09513590.2011.652719.
[7] Tosi F,Di Sarra D,Bonin C,et al. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome[J].Eur J Endocrinol,2014,170(3):401-409.DOI:10.1530/EJE-13-0761.
[8] Piltonen T,Puurunen J,Hedberg P,et al.Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study[J].Hum Reprod,2012,27(10):3046-3056.DOI:10.1093/humrep/des225.
[9] González F,Sia CL,Stanczyk FZ,et al. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome[J].Endocrine,2012,42(3):726-735. DOI:10.1007/s12020-012-9728-6.
[10] Carmina E.Obesity,adipokines and metabolic syndrome in polycystic ovary syndrome[J].Front Horm Res,2013,40:40-50.DOI:10.1159/000341840.
[11] Buyukinan M,Atar M,Can U,et al. The association between serum vaspin and omentin-1 levels in obese children with metabolic syndrome[J].Metab Syndr Relat Disord,2018,16(2):76-81.DOI:10.1089/met.2017.0133.
[12] Yang W,Li Y,Tian T,et al.Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications[J]. BMC Endocr Disord,2017,17(1):67.DOI:10.1186/s12902-017-0216-0.
[13] Waluga M,Kukla M, Z·orniak M,et al.Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease[J].Pol J Pathol,2017,68(2):128-137.DOI:10.5114/pjp.2017.69688.

相似文献/References:

[1]张莎莎,孟杰杰,沈桂芬,等.肌肉生长抑制素前肽基因干预对高脂饮食诱导的肥胖小鼠脂代谢的影响[J].国际内分泌代谢杂志,2014,(06):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
　Zhang Shasha*,Meng Jiejie,Shen Guifen,et al.Effects of myostatin propeptide gene intervention on dyslipidemia in high fat diet-induced obese mice[J].International Journal of Endocrinology and Metabolism,2014,(04):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
[2]杨健姝,华飞,唐暎,等.二甲双胍在多囊卵巢综合征患者妊娠期的应用[J].国际内分泌代谢杂志,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
　Yang Jianshu,Hua Fei,Tang Ying,et al.The application of metformin in the pregnant patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(04):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
[3]郝圆圆,张婷婷,袁红网,等.增食欲素干预单纯性肥胖的作用及机制[J].国际内分泌代谢杂志,2014,(05):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
　Hao Yuanyuan,Zhang Tingting,Yuan Hongwang,et al.Effects of orexin on obesity and its mechanism[J].International Journal of Endocrinology and Metabolism,2014,(04):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
[4]史俊奇 邹朝春.MicroRNA与肥胖[J].国际内分泌代谢杂志,2015,(05):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
　Shi Junqi,Zou Chaochun..MicroRNA and obesity[J].International Journal of Endocrinology and Metabolism,2015,(04):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
[5]张如意 张桦 王娇 孙嘉 陈容平 杨锐 冉建民 陈宏.超重或肥胖2型糖尿病患者糖尿病足的 患病率及相关危险因素分析[J].国际内分泌代谢杂志,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
　Zhang Ruyi*,Zhang Hua,Wang Jiao,et al.Prevalence and risk factors for diabetic foot in overweight or obese type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(04):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
[6]刘剑 吴明昊 高宇.高脂饮食影响消化系统致肥胖的机制[J].国际内分泌代谢杂志,2015,(06):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
　Liu Jian*,Wu Minghao,Gao Yu..The mechanism of obesity caused by disturbance of high fat diets on gastrointestinal system[J].International Journal of Endocrinology and Metabolism,2015,(04):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
[7]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
　Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(04):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
[8]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行 特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
　Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(04):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[9]杨曦,刘玉洁,马慧娟.C1q/肿瘤坏死因子相关蛋白12与糖代谢[J].国际内分泌代谢杂志,2016,36(03):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
　Yang Xi*,Liu Yujie,Ma Huijuan..C1q/tumor necrosis factor-related protein 12 and glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(04):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
[10]赵一璟,陈国芳,刘超.代餐饮食在肥胖和超重患者中的应用[J].国际内分泌代谢杂志,2016,36(05):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
　Zhao Yijing*,Chen Guofang,Liu Chao.Application of meal replacement in obese and overweight patients[J].International Journal of Endocrinology and Metabolism,2016,36(04):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
[11]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(04):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81660142); 贵州省科学技术基金项目(黔科合SY字[2013]3003号); 贵州省科技计划项目(黔科合LH 字[2017]7096号)
通信作者:高琳,Email:lgzymc@sina.com
更新日期/Last Update: 2018-04-30